Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.
about
Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Feasibility and antitumor effi ...... and orlistat in colon cancer.
@ast
Feasibility and antitumor effi ...... and orlistat in colon cancer.
@en
type
label
Feasibility and antitumor effi ...... and orlistat in colon cancer.
@ast
Feasibility and antitumor effi ...... and orlistat in colon cancer.
@en
prefLabel
Feasibility and antitumor effi ...... and orlistat in colon cancer.
@ast
Feasibility and antitumor effi ...... and orlistat in colon cancer.
@en
P2093
P2860
P356
P1433
P1476
Feasibility and antitumor effi ...... and orlistat in colon cancer.
@en
P2093
Alfonso Duenas-Gonzalez
Aurora Gonzalez-Fierro
Catalina Trejo-Becerril
Diana Cervantes-Madrid
Enrique Perez-Cardenas
Guadalupe Dominguez-Gomez
Lucia Taja-Chayeb
P2860
P304
P356
10.3892/OL.2017.5615
P577
2017-01-18T00:00:00Z